02/01/12 - Sophia-Antipolis, France

MEDIAN signe un contrat majeur avec Sanofi

MEDIAN Technologies signe un contrat majeur avec le laboratoire SANOFI pour l’interprétation et la gestion des images dans une nouvelle étude de phase II sur le cancer du poumon à petites cellules.

 

02/01/12 - Sophia-Antipolis, France

MEDIAN has signed a landmark contract with Sanofi

MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.

 
 
/ Home
/ Target Audience

RIS/PACS Providers

Target Audience:RIS/PACS Providers

RIS/PACS Providers need to offer their customers advanced clinical solutions.

  • LMS provides Computer Aided Detection (CAD) of lung nodules.
  • LMS provides repeatable and objective measurement of lung and liver longest axial diameter and volume.
  • LMS provides automatic lesion follow-up and growth calculation.

 

RIS/PACS providers expect advanced clinical solutions to support the routine hospital workflow.

  • LMS can be invocated directly from the PACS application whenever needed.
  • LMS generates a standardized oncology imaging reports that is automatically sent to the PACS.

 

RIS/PACS Providers require that third-party applications integrate seamlessly with existing environments.

  • MEDIAN has developed an Application Programming Interface (API) to facilitate the integration of LMS with RIS/PACS.
  • LMS is a web-based application and does not make extensive usage of bandwidth
  • LMS is based on a modular architecture easily scalable to the existing environment, including in multi-site configurations.